HNB
VRTX icon

Hilltop National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Hilltop National Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
303
+31
+11% +$13.7K 0.03% 295
2026
Q1 		$121K Hold
272
– – 0.03% 310
2025
Q4 		$123K Hold
272
– – 0.03% 300
2025
Q3 		$107K Hold
272
– – 0.03% 337
2025
Q2 		$121K Buy
+272
New +$125K 0.03% 305
2024
Q4 		$8.05K Hold
20
– – ﹤0.01% 651
2024
Q3 		$9.3K Buy
+20
New +$9.61K ﹤0.01% 665

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Hilltop National Bank's VRTX Position: Q2 2026 in Review

Hilltop National Bank increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, buying an estimated $13.7K and bringing the position to 303 shares worth $151K. The position accounts for 0.03% of the portfolio, ranked #295.

Hilltop National Bank first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hilltop National Bank held 303 shares of Vertex Pharmaceuticals worth $151K as of Q2 2026.
  • Hilltop National Bank bought 31 Vertex Pharmaceuticals shares in Q2 2026, an estimated $13.7K.
  • Vertex Pharmaceuticals made up 0.03% of Hilltop National Bank's portfolio in Q2 2026, its #295 holding.
  • Hilltop National Bank first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.